Results 101 to 110 of about 8,896 (223)

Salvage hyperthermic intraperitoneal chemotherapy for appendiceal mucinous adenocarcinoma with peritoneal mucinous carcinomatosis [PDF]

open access: yes, 2018
Appendiceal tumors, particularly those with patterns of advanced malignancy, are rare in clinical practice. This study describes a patient with a mucinous adenocarcinoma originating from the appendix, who also had disseminated peritoneal carcinomatosis ...
Tzu-Chuan Huang   +9 more
core   +1 more source

Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations

open access: yesBMC Cancer, 2006
Background In selected patients with peritoneal carcinomatosis from colorectal cancer prognosis can be improved by hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery.
Dimmler A   +4 more
doaj   +1 more source

Use of FDG-PET/CT for peritoneal carcinomatosis before hyperthermic intraperitoneal chemotherapy [PDF]

open access: yes, 2011
BACKGROUND: Peritoneal carcinomatosis (PC) is associated with a very poor prognosis. Complete cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy has been shown to improve survival rates of PC.
Verrièle, Véronique   +26 more
core   +2 more sources

Long-term survival of high-grade primary peritoneal papillary serous adenocarcinoma: a case report and literature review

open access: yesWorld Journal of Surgical Oncology, 2017
Background Primary peritoneal papillary serous carcinoma (PPPSC) is an uncommon disease which has a high malignancy and a poor prognosis. Case presentation We report here a long-term survival case of PPPSC with postoperative lung metastasis.
Jingping Yuan   +3 more
doaj   +1 more source

Is hyperthermic intraperitoneal chemotherapy (HIPEC) safe for healthcare workers? [PDF]

open access: yes, 2017
International audienceBackgroundDuring hyperthermic intraperitoneal chemotherapy (HIPEC), caregivers are exposed by different routes to cytotoxic drugs.
Simon Rodier   +13 more
core   +1 more source

Assessment of Hyperthermic Intraperitoneal Chemotherapy to Eradicate Intraperitoneal Free Cancer Cells

open access: yesTranslational Oncology, 2016
OBJECTIVE: To assess the effect of hyperthermic intraperitoneal chemotherapy (HIPEC) to eradicate intraperitoneal free cancer cells and to explore the feasibility of cytological cure for peritoneal carcinomatosis (PC).
Zhonghe Ji   +5 more
doaj   +1 more source

Efficacy and safety of intraperitoneal chemotherapy for pancreatic cancer

open access: yesBMC Surgery
Pancreatic cancer is a highly aggressive cancer with unfavorable prognosis despite the therapeutic interventions. Intraperitoneal chemotherapy has recently shown potential outcomes in the presence of peritoneal metastases.
Dorsa Safari   +2 more
doaj   +1 more source

State-of-the-Art Therapy in Peritoneal Carcinomatosis Management

open access: yesOnco
This paper reviews the surgical management of peritoneal carcinomatosis as new surgical methods have been developed within the past few decades. Traditional methods included cytoreductive surgery with hyperthermic intraperitoneal chemotherapy; however, a
Elbek Fozilov   +5 more
doaj   +1 more source

Perioperative fast track program in intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery in advanced ovarian cancer [PDF]

open access: yes, 2011
International audienceDiffuse peritoneal dissemination in advanced ovarian cancer can be treated using optimal effort surgery involving peritonectomy procedures and the administration of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC)
Cascales Campos, Pedro Antonio   +11 more
core   +2 more sources

Inguinal canal recurrence of colorectal adenocarcinoma following cytoreductive surgery and intraperitoneal hyperthermic chemotherapy. [PDF]

open access: yes, 2008
Peritoneal carcinomatosis, the second most common cause of death among patients with colorectal carcinoma, may be managed with cytoreductive surgery and adjuvant intraoperative peritoneal hyperthermic chemotherapy (IHPC). We present the case of a 35-year-
Smaldone, Marc C   +2 more
core  

Home - About - Disclaimer - Privacy